- Home
- CAI vs GMED Comparison
CAI vs GMED Comparison
Compare CAI & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAI
- GMED
- Stock Information
- Founded
- CAI 2008
- GMED 2003
- Country
- CAI United States
- GMED United States
- Employees
- CAI N/A
- GMED N/A
- Industry
- CAI Medical Specialities
- GMED Medical/Dental Instruments
- Sector
- CAI Health Care
- GMED Health Care
- Exchange
- CAI Nasdaq
- GMED Nasdaq
- Market Cap
- CAI 7.7B
- GMED 8.1B
- IPO Year
- CAI 2025
- GMED 2012
- Fundamental
- Price
- CAI $30.29
- GMED $53.40
- Analyst Decision
- CAI Strong Buy
- GMED Buy
- Analyst Count
- CAI 6
- GMED 13
- Target Price
- CAI $32.33
- GMED $90.00
- AVG Volume (30 Days)
- CAI 692.5K
- GMED 1.7M
- Earning Date
- CAI 08-03-2021
- GMED 08-07-2025
- Dividend Yield
- CAI N/A
- GMED N/A
- EPS Growth
- CAI N/A
- GMED 145.70
- EPS
- CAI N/A
- GMED 1.34
- Revenue
- CAI $452,498,000.00
- GMED $2,510,810,000.00
- Revenue This Year
- CAI N/A
- GMED $15.47
- Revenue Next Year
- CAI N/A
- GMED $8.53
- P/E Ratio
- CAI N/A
- GMED $39.68
- Revenue Growth
- CAI 34.67
- GMED 32.26
- 52 Week Low
- CAI $25.40
- GMED $51.87
- 52 Week High
- CAI $33.41
- GMED $94.93
- Technical
- Relative Strength Index (RSI)
- CAI N/A
- GMED 31.95
- Support Level
- CAI N/A
- GMED $51.87
- Resistance Level
- CAI N/A
- GMED $57.99
- Average True Range (ATR)
- CAI 0.00
- GMED 1.55
- MACD
- CAI 0.00
- GMED -0.40
- Stochastic Oscillator
- CAI 0.00
- GMED 5.44
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.